All In Biotech

Free tool

FAERS Monitor: Trental

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018631 or its brand name (Trental, Pentoxifylline). Reports on generic versions are filed under their own applications.

Reports

5,864

Serious

4,790

82% of reports

Hospitalization

2,322

Death reported

941

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue544
  • diarrhoea522
  • dyspnoea498
  • nausea488
  • drug ineffective472
  • dizziness466
  • asthenia439
  • fall426
  • headache425
  • insomnia375
  • arthralgia366
  • vomiting356
  • pruritus342
  • off label use340
  • decreased appetite320

Reports by year received

View as table
YearReports
2004168
2005159
2006160
2007116
2008140
2009176
2010201
2011230
2012288
2013159
2014214
2015217
2016283
2017274
2018358
2019364
2020336
2021383
2022383
2023379
2024366
2025326
2026182

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,295 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
insomniaSignal3755.14.61,230
decreased appetiteSignal3204.94.41,014
fallSignal4264.64.21,212
astheniaSignal4394.23.81,082
dizzinessSignal4663.43.1785
pruritusSignal3423.22.9522
arthralgiaSignal3663.22.9548
dyspnoeaSignal4983.22.9751
diarrhoeaSignal5222.92.7669
vomitingSignal3562.72.5393
fatigueSignal5442.52.3510
headacheSignal4252.42.2368
nauseaSignal4882.22.0335
off label use3401.41.339
drug ineffective4721.31.231

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.